Belgium bans use of Ozempic for weight loss until summer, Top Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com

Ozempic is approved to treat Type 2 diabetes but has increasingly been prescribed “off-label” to treat weight loss because it has the same active ingredient as Novo’s hugely popular – and scarce – anti-obesity drug Wegovy., Ozempic is approved to treat Type 2 diabetes but has increasingly been prescribed “off-label” to treat weight loss because it has the same active ingredient as Novo’s hugely popular – and scarce – anti-obesity drug Wegovy., , Read More